# Acupoint Stimulation and Cranial Endovascular Treatment

Study · id `cardio:ct-nct05413460` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05413460](<https://clinicaltrials.gov/study/NCT05413460>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05413460

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 158 participants.

## Technical summary

Registry record NCT05413460. Randomized; quadruple masking; primary purpose prevention. Start 2022-07-26 (actual); primary completion 2023-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 158 participants (planned count; ClinicalTrials.gov record NCT05413460, source copy `cardio:ctgov-nct05413460-2022-12-06`, retrieved 2026-11-18)
- Started: 2022-07-26 (actual) (ClinicalTrials.gov record NCT05413460, source copy `cardio:ctgov-nct05413460-2022-12-06`, retrieved 2026-11-18)
- Primary completion: 2023-06-30 (anticipated) (ClinicalTrials.gov record NCT05413460, source copy `cardio:ctgov-nct05413460-2022-12-06`, retrieved 2026-11-18)
- Completion: 2023-06-30 (anticipated) (ClinicalTrials.gov record NCT05413460, source copy `cardio:ctgov-nct05413460-2022-12-06`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT05413460, source copy `cardio:ctgov-nct05413460-2022-12-06`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05413460-2022-12-06`, retrieved 2026-11-18)

## The registry's words

- Brief title: Acupoint Stimulation and Cranial Endovascular Treatment
- Acronym: ASSET
- Condition: Cerebral Aneurysm
- Intervention (Device): transcutaneous electrical acupoint stimulation
- Lead sponsor: Zhihong LU
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Brain aneurysm (intracranial aneurysm) (`cardio:intracranial-aneurysm`)

## Provenance

Content hash: cc0ada71d0fc329d047d8cb5db84bc505388d3d016c5d464069e5a1021966751
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
